SCHEMBL20184780

SCHEMBL20184780

Fc1cccc([B-](c2cccc(F)c2)(c2cccc(F)c2)c2cccc(F)c2)c1.c1ccc(CN2CCC[N+]3=C2CCCCC3)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
GRM2 Q14416 1/20 0.34
CYP2D6 P10635 4/20 0.33
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MAPK1 P28482 1/20 0.33
FABP4 P15090 1/20 0.33
CLPP Q16740 1/20 0.33
RECQL P46063 1/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PTGER4 P35408 1/20 0.32
PTGER2 P43116 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29876820 0.89 L3MBTL1 (0.47) L3MBTL1NPC1RAB9ACYP2D6LMNA
Bromide SCHEMBL20184792 0.82 L3MBTL1 (0.53) L3MBTL1NPC1RAB9ACYP2D6LMNA
SCHEMBL985844 0.63 ACHE (0.46) NPC1RAB9ACYP2D6MAPK1CYP1A2
SCHEMBL17309675 0.62 CHKA (0.40) L3MBTL1HTTNPSR1
Lithium Ion SCHEMBL29567744 0.61 ACHE (0.44) NPC1RAB9ACYP2D6MAPK1CYP1A2
Silver SCHEMBL29830980 0.61 ACHE (0.44) NPC1RAB9ACYP2D6MAPK1CYP1A2
SCHEMBL912803 0.61 ACHE (0.44) NPC1RAB9ACYP2D6MAPK1CYP1A2
Lithium Ion SCHEMBL1451578 0.61 ACHE (0.44) NPC1RAB9ACYP2D6MAPK1CYP1A2
Silver SCHEMBL1452545 0.61 ACHE (0.44) NPC1RAB9ACYP2D6MAPK1CYP1A2
SCHEMBL1450851 0.61 ACHE (0.44) NPC1RAB9ACYP2D6MAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3327002-B1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-01 US disclosed
US-20190002403-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-01-03 US disclosed
EP-3327002-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR Wako Pure Chemical Industries, Ltd. (JP) 2018-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator REV1, RER1, CBR1 L3MBTL1 1943/4885ALDH1A1 847/4885SMN1; SMN2 1447/4885
US-20190002403-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR REV1, RER1, CBR1 L3MBTL1 1943/4885ALDH1A1 847/4885SMN1; SMN2 1447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.